Sharekhan

BUY NOW Buy Vivanza Biosciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Vivanza Biosciences Ltd

Thu 22/01/2026,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Vivanza Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vivanza Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vivanza Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    20 Jan 2026, 5:50PM As of December 2025, 20.02% is owned by Indian Promoters and 79.98% by Public. <p align=justify> Top two Promoters holding highest number of shares of

  • Vivanza Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    2 Jan 2026, 5:51PM We hereby enclose the Confirmation Certificate Under regulation 74(5) of SEBI (Depositories and participants) Regulations, 2018 received from Purva Sh

  • Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    18 Dec 2025, 2:35PM Pursuant to Regulation 30(2) of SEBI, LODR Regulations, 2015 and SEBI Circular Dated November 11, 2024 the members have approved, by Special Resolutio

  • Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    17 Dec 2025, 6:01PM Voting Results and Scrutinizer Report of Postal Ballot

  • Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    17 Dec 2025, 5:58PM Proceedings/Outcome of Postal Ballot

  • Vivanza Biosciences - Reg. 34 (1) Annual Report.

    4 Dec 2025, 4:38PM This is to inform that, pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of o

  • Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    14 Nov 2025, 3:48PM Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit the postal ballot notice for seeking Members' approval for the alteration

  • Vivanza Biosciences - Results - Financial Results For 30Th September, 2025

    14 Nov 2025, 1:07PM Pursuant to regulations 30 & 33 of SEBI (LODR), we inform that the Board at its meeting held on November 11, 2025, approved:\r\n1. Un-audited & Standa

  • Vivanza Biosciences Q2 net profit zooms 4500.00% at Rs 0.46 cr

    12 Nov 2025, 2:22PM The company reported standalone net profit of Rs 0.46 crore for the quarter ended September 30, 2025 as compared to Rs 0.01 crore in the same period l

  • Vivanza Biosciences - Non-Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter

    11 Nov 2025, 6:35PM Announcement regarding Non-Applicability of Related Party Transaction under Regulation 23(9) of SEBI LODR

  • Vivanza Biosciences - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligatio

    11 Nov 2025, 6:32PM Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, attaching herewith Non-Applicability of Statement of deviation or variation

  • Vivanza Biosciences - Postal Ballot For Alteration Of The Main Object Clause Of The Memorandum Of Association Of The Company

    11 Nov 2025, 5:44PM The board has approved conducting a Postal Ballot to seek members' consent for altering the main Object clause of Memorandum of Association. Members w

  • Vivanza Biosciences - Financial Results For The Quarter Ended 30Th September, 2025

    11 Nov 2025, 5:34PM Pursuant to Regulation 30 and 33 of the SEBI (LODR) Regulations, 2015 we wish to inform that the board of directors at its meeting held tuesday 11th N

  • Vivanza Biosciences - Board Meeting Outcome for The Board Meeting Held On 11Th November, 2025

    11 Nov 2025, 5:08PM Pursuant to Regulations 30 and 33 of the SEBI (LODR) Regulations, 2015, we wish to inform that the Board of Directors, at its meeting held on Tuesday,

  • Vivanza Biosciences - Board Meeting Intimation for Notice For The Meeting Of The Board Of Directors Pursuant To Regulation 29

    3 Nov 2025, 11:05AM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Vivanza Biosciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 10.113 7.9781 10.9623 5.5128 3.5404
Liabilities 10.113 7.9781 10.9623 5.5128 3.5404
Equity 4 4 4 4 4
Gross Profit -0.3634 0.7998 0.7212 0.049 0.1259
Net Profit -0.6951 0.3174 0.5691 0.4636 0.0998
Cash From Operating Activities -2.4688 1.7835 0.1607 -0.6771 -3.0778
NPM(%) -23.62 2.2 4 5.06 1.08
Revenue 2.9428 14.4132 14.2071 9.1475 9.2233
Expenses 3.3062 13.6134 13.4859 9.0984 9.0973
ROE(%) -15.06 6.87 12.33 10.04 2.16

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vivanza Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 688.00 0.44 0.00 1.23 301.39 0.73
Lotus Eye Hospital and Institute Ltd 116.15 4.97 363.66 4.47 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.63 3.22 0.00 9.28 -39.50 0.00
Astec Lifesciences Ltd 592.45 0.95 0.00 4.22 -604.77 0.00

Company Info

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Read More

Parent Organisation

Vivanza Biosciences Ltd.

Founded

06/03/1982

Managing Director

Mr.J A Mehta

NSE Symbol

FAQ

The current price of Vivanza Biosciences Ltd is

The 52-week high for Vivanza Biosciences Ltd is

The market capitalization of Vivanza Biosciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vivanza Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vivanza Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vivanza Biosciences Ltd shares.

The CEO of Vivanza Biosciences Ltd is Mr.J A Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT